TAK-788
AP32788-15-101
Phase 2 small_molecule active
Quick answer
TAK-788 for Carcinoma, Non-Small-Cell Lung is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active